Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.
Also called NCT06358313
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 600 participants
- Sponsor
- Registry
-
NCT06358313
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Recruiting
Technical summary
Registry record NCT06358313. Randomized; double masking; primary purpose treatment. Start 2024-04-10 (actual); primary completion 2026-05-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Atorvastatin 40mg
- Intervention (Drug)
- Rosuvastatin 20mg
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06358313- Content hash
2c70d39b1122bf7094d93708a71117d5f8401eea1c02c193ded8704f7178464b